Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Cornelli

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.
Panminerva Medica|March 23, 2020
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registryAndrea Ledda, Umberto Cornelli, Gianni Belcaro, et al.
Journal of Neurosurgical Sciences|June 26, 2018
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit®Gianni Belcaro, Aristide Saggino, Umberto Cornelli, et al.
Thrombosis Research|June 14, 2002
The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3Qing Ma, Bertalan Dudas, Matthew Hejna, et al.
Transplantation|December 6, 2003
Oxidative stress in kidney transplant patientsMariarosaria Campise, Fabrizia Bamonti, Cristina Novembrino, et al.
Current Pharmaceutical Design|May 17, 2007
Heparin oligosaccharides as potential therapeutic agents in senile dementiaQing Ma, Umberto Cornelli, Israel Hanin, et al.
Thrombosis Research|February 28, 2004
Pharmacodynamics and pharmacokinetics of C3, a heparin-derived oligosaccharide mixture, in non-human primatesQing Ma, Christopher Schultz, Brian Neville, et al.
Journal of Clinical Medicine|July 16, 2020
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed<sup>®</sup> Versus PlaceboBruna Sinjari, Beatrice Feragalli, Umberto Cornelli, et al.
Phytotherapy Research : PTR|May 1, 2009
Daily consumption of Reliv Glucaffect for 8 weeks significantly lowered blood glucose and body weight in 50 subjectsGianni Belcaro, Maria Cesarone, Errichi Silvia, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|June 25, 2002
Low molecular weight glycosaminoglycan blockade of beta-amyloid induced neuropathologyMark Walzer, Stanley Lorens, Matthew Hejna, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 9, 2006
Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysisJyothi Maddineni, Walter P Jeske, Francis Baltasar, et al.
Panminerva Medica|March 23, 2020
Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registryAndrea Ledda, Umberto Cornelli, Gianni Belcaro, et al.
Journal of Neurosurgical Sciences|June 26, 2018
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit®Gianni Belcaro, Aristide Saggino, Umberto Cornelli, et al.
Thrombosis Research|June 14, 2002
The blood-brain barrier accessibility of a heparin-derived oligosaccharides C3Qing Ma, Bertalan Dudas, Matthew Hejna, et al.
Transplantation|December 6, 2003
Oxidative stress in kidney transplant patientsMariarosaria Campise, Fabrizia Bamonti, Cristina Novembrino, et al.
Current Pharmaceutical Design|May 17, 2007
Heparin oligosaccharides as potential therapeutic agents in senile dementiaQing Ma, Umberto Cornelli, Israel Hanin, et al.
Thrombosis Research|February 28, 2004
Pharmacodynamics and pharmacokinetics of C3, a heparin-derived oligosaccharide mixture, in non-human primatesQing Ma, Christopher Schultz, Brian Neville, et al.
Journal of Clinical Medicine|July 16, 2020
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed<sup>®</sup> Versus PlaceboBruna Sinjari, Beatrice Feragalli, Umberto Cornelli, et al.
Phytotherapy Research : PTR|May 1, 2009
Daily consumption of Reliv Glucaffect for 8 weeks significantly lowered blood glucose and body weight in 50 subjectsGianni Belcaro, Maria Cesarone, Errichi Silvia, et al.
Pageof 8